Ever Source Wealth Advisors, LLC Candel Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 38 shares of CADL stock, worth $217. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38Holding current value
$217% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CADL
# of Institutions
88Shares Held
15.2MCall Options Held
536KPut Options Held
335K-
Baker Bros. Advisors LP New York, NY2.44MShares$13.9 Million0.16% of portfolio
-
Acorn Capital Advisors, LLC New York, NY2.15MShares$12.3 Million8.46% of portfolio
-
Northpond Ventures, LLC1.94MShares$11.1 Million48.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.74MShares$9.93 Million0.0% of portfolio
-
Portolan Capital Management, LLC Boston, MA881KShares$5.04 Million0.41% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $165M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...